Advise the patient to read the
FDA-approved patient labeling(Patient Information and Instructions for Use).
Never Share a NOVOLOG MIX 70/30 FlexPen between Patients
Advise patients that they must never share NOVOLOG MIX 70/30 FlexPen device with another person even if the needle is changed. Advise patients using NOVOLOG MIX 70/30 vials not to share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens
[see Warnings and Precautions (5.1)].
Hyperglycemia or Hypoglycemia
Inform patients that hypoglycemia is the most common adverse reaction with insulin. Instruct patients on self-management procedures including glucose monitoring, proper injection technique, and management of hypoglycemia and hyperglycemia, especially at initiation of NOVOLOG MIX 70/30 therapy. Instruct patients on handling of special situations such as intercurrent conditions (illness, stress, or emotional disturbances), an inadequate or skipped insulin dose, inadvertent administration of an increased insulin dose, inadequate food intake, and skipped meals. Instruct patients on the management of hypoglycemia
[see Warnings and Precautions (5.3)].
Inform patients that their ability to concentrate and react may be impaired as a result of hypoglycemia. Advise patients who have frequent hypoglycemia or reduced or absent warning signs of hypoglycemia to use caution when driving or operating machinery.
Advise patients that changes in insulin regimen can predispose to hyperglycemia or hypoglycemia and that changes in insulin regimen should be made under close medical supervision
[see Warnings and Precautions (5.2)]
.
Hypoglycemia with Medication Errors
Instruct patients to always check the insulin label before each injection to avoid mix-ups between insulin products
[see Warnings and Precautions (5.4)].
Hypersensitivity Reactions
Advise patients that hypersensitivity reactions have occurred with NOVOLOG MIX 70/30. Inform patients of the symptoms of hypersensitivity reactions
[see Warnings and Precautions (5.5)].
Manufactured by:
Novo Nordisk Inc.
800 Scudders Mill Road
Plainsboro, NJ 08536
U.S. License Number 1261
Version: 18
Novo Nordisk
®, NOVOLOG
®, FlexPen
®, and Novolin
®are registered trademarks of Novo Nordisk
®A/S.
ReliOn
® is a registered trademark of Walmart Inc. and is used under license by Novo Nordisk Inc.
Patent Information:
http://novonordisk-us.com/products/product-patents.html
© 2023 Novo Nordisk
For additional information about NOVOLOG MIX 70/30 contact:
www.novonordisk-us.com
Repackaged By / Distributed By: RemedyRepack Inc.
625 Kolter Drive, Indiana, PA 15701
(724) 465-8762